Page last updated: 2024-08-24

sparfloxacin and Mycoplasma dispar Infection

sparfloxacin has been researched along with Mycoplasma dispar Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kai, Y; Kuroki, M; Matsuyama, M; Murai, K; Nagatomo, Y; Okayama, A; Sasaki, T; Tanaka, G; Tsubouchi, H1
Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R1
Hara, K; Ishida, K; Kaku, M; Koga, H; Kohno, S; Usui, T1
Hayashi, Y; Ito, G; Takeyama, S1

Trials

1 trial(s) available for sparfloxacin and Mycoplasma dispar Infection

ArticleYear
Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Animals; Anti-Infective Agents; Cricetinae; Fluoroquinolones; Humans; Lung; Male; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones

1995

Other Studies

3 other study(ies) available for sparfloxacin and Mycoplasma dispar Infection

ArticleYear
[Mycoplasma pneumonia of identical twin sisters with different clinical courses depending on the treatment].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Diseases in Twins; Female; Fluoroquinolones; Humans; Methylprednisolone; Pneumonia, Mycoplasma

2002
In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:4

    Topics: Animals; Anti-Infective Agents; Cricetinae; Fluoroquinolones; Humans; Levofloxacin; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones

1994
[Clinical study on sparfloxacin (SPFX) in the treatment of mycoplasmal pneumonia and penetration of SPFX to the pneumonic lesion].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1998, Volume: 72, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Bacterial Translocation; Bronchoalveolar Lavage Fluid; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycoplasma; Pneumonia, Mycoplasma; Quinolones

1998